WO2003020953A3 - Compositions et procedes concernant des genes et des proteines specifiques du colon - Google Patents

Compositions et procedes concernant des genes et des proteines specifiques du colon Download PDF

Info

Publication number
WO2003020953A3
WO2003020953A3 PCT/US2002/027728 US0227728W WO03020953A3 WO 2003020953 A3 WO2003020953 A3 WO 2003020953A3 US 0227728 W US0227728 W US 0227728W WO 03020953 A3 WO03020953 A3 WO 03020953A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
colon
compositions
antagonists
agonists
Prior art date
Application number
PCT/US2002/027728
Other languages
English (en)
Other versions
WO2003020953A2 (fr
Inventor
Yongming Sun
Chenghua Liu
Malavika G Ghosh
Original Assignee
Diadexus Inc
Yongming Sun
Chenghua Liu
Malavika G Ghosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc, Yongming Sun, Chenghua Liu, Malavika G Ghosh filed Critical Diadexus Inc
Priority to AU2002339859A priority Critical patent/AU2002339859A1/en
Publication of WO2003020953A2 publication Critical patent/WO2003020953A2/fr
Publication of WO2003020953A3 publication Critical patent/WO2003020953A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des molécules d'acides nucléiques et des polypeptides récemment identifiés, présents dans les cellules normales et néoplasiques du côlon, notamment des fragments, des variants et des dérivés de ces acides nucléiques et de ces polypeptides. L'invention concerne également des anticorps, ainsi que des agonistes et des antiagonistes desdits polypeptides. L'invention concerne également des compositions contenant lesdites molécules d'acides nucléiques, lesdits polypeptides, lesdits anticorps, lesdits agonistes et lesdits antiagonistes ainsi que les procédés d'utilisation de ces compositions. Ces utilisations consistent à identifier, diagnostiquer, contrôler, déterminer un stade, imager et traiter le cancer du côlon et les états pathologiques non cancéreux dans des tissus du côlon, identifier des tissus du côlon, contrôler et identifier et/ou élaborer des antagonistes ou des polypeptides selon l'invention. Ces utilisations comprennent également la thérapie génique, la production d'animaux et de cellules transgéniques, et la production de tissus du côlon mis au point à des fins de recherche et de traitement.
PCT/US2002/027728 2001-08-31 2002-08-29 Compositions et procedes concernant des genes et des proteines specifiques du colon WO2003020953A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002339859A AU2002339859A1 (en) 2001-08-31 2002-08-29 Compositions and methods relating to colon specific genes and proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31625901P 2001-08-31 2001-08-31
US60/316,259 2001-08-31

Publications (2)

Publication Number Publication Date
WO2003020953A2 WO2003020953A2 (fr) 2003-03-13
WO2003020953A3 true WO2003020953A3 (fr) 2004-01-29

Family

ID=23228274

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/027728 WO2003020953A2 (fr) 2001-08-31 2002-08-29 Compositions et procedes concernant des genes et des proteines specifiques du colon

Country Status (2)

Country Link
AU (1) AU2002339859A1 (fr)
WO (1) WO2003020953A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
GB0403142D0 (en) * 2004-02-12 2004-03-17 Ares Trading Sa Protein
JP5022906B2 (ja) * 2004-11-24 2012-09-12 テラプトシス エス アー カスパーゼ−２／−６二重阻害剤として有用な新規ペプチドおよびそれらの生物学的適用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117654A (en) * 1997-08-04 2000-09-12 Millennium Biotherapeutics, Inc. Nucleic acid molecules encoding Tango-77-polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117654A (en) * 1997-08-04 2000-09-12 Millennium Biotherapeutics, Inc. Nucleic acid molecules encoding Tango-77-polypeptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 1 September 2000 (2000-09-01), WATERSTON R.H.: "The sequence of homo sapiens clone", XP002967941, accession no. NCBI Database accession no. (AC024725) *
DATABASE GENBANK [online] 7 May 2001 (2001-05-07), STRAUSBERG R.: "National Instituted of health, mammalian gene collection", XP002967942, accession no. NCBI Database accession no. (BG696484) *

Also Published As

Publication number Publication date
WO2003020953A2 (fr) 2003-03-13
AU2002339859A1 (en) 2003-03-18

Similar Documents

Publication Publication Date Title
WO2004053079A3 (fr) Compositions, variants d'epissage et methodes concernant des genes et des proteines specifiques des ovaires
WO2002062945A3 (fr) Compositions et techniques relatives a des genes et a des proteines specifiques du poumon
WO2002055735A3 (fr) Compositions et methodes en rapport avec des genes et des proteines specifiques de la prostate
WO2002064741A3 (fr) Compositions et methodes concernant des genes et des proteines specifiques du sein
WO2002040673A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux poumons
WO2004053075A3 (fr) Compositions, variants d'epissage et procedes relatifs a des genes et des proteines specifiques du sein
WO2004050860A3 (fr) Compositions, variants d'epissage et methodes associes aux genes et proteines specifiques du colon
WO2005017102A3 (fr) Compositions, variants d'epissage et procedes associes a des acides nucleiques et des proteines specifiques
WO2004013311A3 (fr) Compositions et methodes se rapportant a des genes et proteines specifiques de l'ovaire
WO2003106648A3 (fr) Compositions et methodes associees a des genes et a des proteines specifiques du sein
WO2004050858A3 (fr) Compositions, variants d'epissage et procedes associe aux genes et proteines specifiques du colon
WO2003066877A3 (fr) Compositions et procedes se rapportant a des genes et proteines specifiques hepatiques
WO2002064788A3 (fr) Compositions et procedes relatifs aux genes et aux proteines specifiques aux poumons
WO2004052290A3 (fr) Compositions, variants d'epissage et procedes concernant des genes et proteines specifiques du sein
WO2003020953A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques du colon
WO2003020899A3 (fr) Compositions et methodes relatives a des genes et proteines specifiques des poumons
WO2002039431A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques de la prostate
WO2002042776A3 (fr) Compositions contenant des genes et des proteines specifiques a la prostate, et methodes faisant appel a ces genes et proteines
WO2004053077A3 (fr) Compositions, variants d'epissure et techniques liees aux genes et aux proteines specifiques du sein
WO2003060121A3 (fr) Compositions et procedes relatifs a des proteines et a des genes gastriques specifiques
WO2003020901A3 (fr) Compositions et procedes se rapportant aux genes et aux proteines specifiques de la prostate
WO2003060081A3 (fr) Compositions et procedes relatifs aux genes et aux proteines specifiques endometriaux
WO2003055982A3 (fr) Compositions et procedes se rattachant a des genes et proteines specifiques endometriaux
WO2002046224A3 (fr) Compositions et procedes relatifs a des genes et proteines specifiques des poumons
WO2002066605A3 (fr) Compositions et procedes relatifs a des genes et a des proteines specifiques du sein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP